Cargando…

Age and Cytokine Gene Variants Modulate the Immunogenicity and Protective Effect of SARS-CoV-2 mRNA-Based Vaccination

The introduction of anti-SARS-CoV-2 vaccines in late 2020 substantially changed the pandemic picture, inducing effective protection in the population. However, individual variability was observed with different levels of cellular response and neutralizing antibodies. We report data on the impact of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scola, Letizia, Ferraro, Donatella, Sanfilippo, Giuseppa Luisa, De Grazia, Simona, Lio, Domenico, Giammanco, Giovanni Maurizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962548/ https://www.ncbi.nlm.nih.gov/pubmed/36851291 http://dx.doi.org/10.3390/vaccines11020413

Ejemplares similares

IL-1 Superfamily Member (IL-1A, IL-1B and IL-18) Genetic Variants Influence Susceptibility and Clinical Course of Mediterranean Spotter Fever
por: Scola, Letizia, et al.
Publicado: (2022)

Neutralizing Antibodies Response against SARS-CoV-2 Variants of Concern Elicited by Prior Infection or mRNA BNT162b2 Vaccination
por: Bonura, Floriana, et al.
Publicado: (2022)

An Analysis of the Neutralizing Antibodies against the Main SARS-CoV-2 Variants in Healthcare Workers (HCWs) Vaccinated against or Infected by SARS-CoV-2
por: Immordino, Palmira, et al.
Publicado: (2023)

Polymorphisms of Pro-Inflammatory IL-6 and IL-1β Cytokines in Ascending Aortic Aneurysms as Genetic Modifiers and Predictive and Prognostic Biomarkers
por: Scola, Letizia, et al.
Publicado: (2021)

TGF-β/VEGF-A Genetic Variants Interplay in Genetic Susceptibility to Non-Melanocytic Skin Cancer
por: Scola, Letizia, et al.
Publicado: (2022)

Antibodies Responses to SARS-CoV-2 in a Large Cohort of Vaccinated Subjects and Seropositive Patients
por: Amodio, Emanuele, et al.
Publicado: (2021)

SARS CoV2 infection _The longevity study perspectives
por: Lio, Domenico, et al.
Publicado: (2021)

On the Road to Accurate Biomarkers for Cardiometabolic Diseases by Integrating Precision and Gender Medicine Approaches
por: Scola, Letizia, et al.
Publicado: (2019)

α-Lipoic Acid and Superoxide Dismutase in the Management of Chronic Neck Pain: A Prospective Randomized Study
por: Letizia Mauro, Giulia, et al.
Publicado: (2014)

Susceptibility to Heart Defects in Down Syndrome Is Associated with Single Nucleotide Polymorphisms in HAS 21 Interferon Receptor Cluster and VEGFA Genes
por: Balistreri, Carmela Rita, et al.
Publicado: (2020)

Construction and Immunogenicity of Modified mRNA-Vaccine Variants Encoding Influenza Virus Antigens
por: Starostina, Ekaterina V., et al.
Publicado: (2021)

Immunogenicity mechanism of mRNA vaccines and their limitations in promoting adaptive protection against SARS-CoV-2
por: Salleh, Mohd Zulkifli, et al.
Publicado: (2022)

Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variants
por: Logue, James, et al.
Publicado: (2023)

Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis
por: Choi, Angela, et al.
Publicado: (2021)

Manganese-coordinated mRNA vaccines with enhanced mRNA expression and immunogenicity induce robust immune responses against SARS-CoV-2 variants
por: Fan, Na, et al.
Publicado: (2022)

Assessment of SARS-CoV-2 RNA shedding in semen of 36 males with symptomatic, asymptomatic, and convalescent infection during the first and second wave of COVID-19 pandemic in Italy
por: Pavone, Carlo, et al.
Publicado: (2022)

Immunogenicity, effectiveness, safety and psychological impact of COVID-19 mRNA vaccines
por: Alesci, Alessio, et al.
Publicado: (2022)

Viral immunogenic footprints conferring T cell cross-protection to SARS-CoV-2 and its variants
por: Antonio, Eduardo Cheuiche, et al.
Publicado: (2022)

Design of immunogens for eliciting antibody responses that may protect against SARS-CoV-2 variants
por: Wang, Eric, et al.
Publicado: (2022)

Design of immunogens for eliciting antibody responses that may protect against SARS-CoV-2 variants
por: Wang, Eric, et al.
Publicado: (2023)

Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection
por: Espeseth, Amy S., et al.
Publicado: (2020)

COVID-19 mRNA vaccine safety, immunogenicity, and effectiveness in a hospital setting: confronting the challenge
por: Sultana, Janet, et al.
Publicado: (2022)

Immunogenicity and Protection Efficacy of a Naked Self-Replicating mRNA-Based Zika Virus Vaccine
por: Zhong, Zifu, et al.
Publicado: (2019)

Immunogenicity and protective activity of mRNA vaccine candidates against yellow fever virus in animal models
por: Medina-Magües, Lex G., et al.
Publicado: (2023)

MIF rs755622 and IL6 rs1800795 Are Implied in Genetic Susceptibility to End-Stage Renal Disease (ESRD)
por: Guarneri, Marco, et al.
Publicado: (2022)

Role of TGF-β Pathway Polymorphisms in Sporadic Thoracic Aortic Aneurysm: rs900 TGF-β2 Is a Marker of Differential Gender Susceptibility
por: Scola, Letizia, et al.
Publicado: (2014)

Reduced SARS-CoV-2 mRNA vaccine immunogenicity and protection in mice with diet-induced obesity and insulin resistance
por: O’Meara, Timothy R., et al.
Publicado: (2022)

Protection against two spontaneous mouse leukemias conferred by immunogenic variants obtained by mutagenesis
Publicado: (1983)

Immunogenicity and protective efficacy of SARS-CoV-2 mRNA vaccine encoding secreted non-stabilized spike in female mice
por: Prompetchara, Eakachai, et al.
Publicado: (2023)

Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapies
por: Capone, Fioravante, et al.
Publicado: (2021)

Immunogenicity of BA.5 Bivalent mRNA Vaccine Boosters
por: Collier, Ai-ris Y., et al.
Publicado: (2023)

Adenovirus vector and mRNA vaccines: Mechanisms regulating their immunogenicity
por: Provine, Nicholas M., et al.
Publicado: (2022)

Immunogenicity of the BA.5 Bivalent mRNA Vaccine Boosters
por: Collier, Ai-ris Y., et al.
Publicado: (2022)

Construction and immunogenicity of an mRNA vaccine against chikungunya virus
por: Liu, Jingjing, et al.
Publicado: (2023)

Algorithm for optimized mRNA design improves stability and immunogenicity
por: Zhang, He, et al.
Publicado: (2023)

Knife’s edge: Balancing immunogenicity and reactogenicity in mRNA vaccines
por: Lee, Jisun, et al.
Publicado: (2023)

Erythropoietin stimulation of human adipose tissue for therapeutic refilling releases protective cytokines
por: Sabbatini, Maurizio, et al.
Publicado: (2016)

Immunogenicity of Sars-Cov-2 mRNA 1273 Vaccine in Patients with Lymphoid Malignancies
por: Dong, Ning, et al.
Publicado: (2021)

Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine
por: Zeng, Guangting
Publicado: (2022)

Safety and Cross-Variant Immunogenicity of a Three-dose COVID-19 mRNA Vaccine Regimen in Kidney Transplant Recipients
por: Massa, Filippo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d7hit7anlgsnrddkls3vn95b0m